用Acinetobacter baumannii粘附蛋白Abp2D进行疫苗接种,可以预防导管相关的尿路感染

相关实验视频

Updated: Jul 18, 2025

07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

138

Morgan R Timm¹, Kevin O Tamadonfar¹, Taylor M Nye¹

¹Department of Molecular Microbiology and Center for Women's Infectious Disease Research, Washington University School of Medicine, St. Louis, MO, USA.

Research square

|August 23, 2023

概括

一种针对Acinetobacter baumannii粘附的新型疫苗显著减少了小鼠的导管相关尿路感染 (CAUTIs). 仅对Abp2D粘附蛋白的免疫力就提供了保护,为抗生素耐药细菌提供了新的策略.

科学领域:

微生物学微生物学
免疫学免疫学免疫学
传染性疾病传染性疾病

背景情况:

导管相关的尿路感染 (CAUTIs) 是一个重要的医疗负担.
抗生素耐药的Acinetobacter baumannii是一种新兴的CAUTI病原体.
在A.I.A.中, 宝曼尼 (baumannii) 使用纤维素原结合粘合素 (Abp1D,Abp2D) 进行导管殖民和生物膜形成.

研究的目的:

开发和评估一种针对亚亚的蛋白子单元疫苗. 宝曼尼粘合剂用于预防CAUTI.
为了确定针对特定粘合素的保护效果,特别是Abp2D.
阐明疫苗诱导保护的基础免疫机制.

主要方法:

开发一种针对Abp1D_RBD和Abp2D_RBD的蛋白质子单元疫苗.
在A.A.小鼠模型中评估疫苗的疗效. baumannii CAUTI. 需要注意的是
评估免疫反应,包括B细胞激活和免疫的被动转移.

主要成果:

在CAUTI小鼠模型中,接种疫苗显著降低了膀中的细菌标位.
仅仅对Abp2D_RBD的免疫力就足以保护人们免受A. baumannii CAUTI. 需要注意的是
通过免疫血清的被动免疫赋予了保护,表明抗体介导免疫.

结论:

一种针对A.A.的新型蛋白质子单元疫苗. 宝曼尼粘合剂是有效的预防CAUTI.
Abp2D_RBD是针对阿尔茨海默病的疫苗开发的一个关键目标. baumannii CAUTI. 需要注意的是
这一策略为对抗抗生素耐药性AI提供了一个有前途的方法. 人类感染和抗菌素耐药性.

相关概念视频

01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...

01:22

Healthcare Associated Infections II: Preventive Measures

2.7K

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

2.7K

01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.3K

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

1.3K

01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...

01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...

01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...